Russell Investments Group’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$360K Sell
98,823
-9,329
-9% -$34K ﹤0.01% 2464
2025
Q1
$208K Sell
108,152
-2,778
-3% -$5.33K ﹤0.01% 2582
2024
Q4
$211K Sell
110,930
-59,444
-35% -$113K ﹤0.01% 2523
2024
Q3
$225K Sell
170,374
-5,428
-3% -$7.17K ﹤0.01% 2483
2024
Q2
$179K Hold
175,802
﹤0.01% 2503
2024
Q1
$322K Sell
175,802
-6,259
-3% -$11.5K ﹤0.01% 2343
2023
Q4
$226K Sell
182,061
-5,689
-3% -$7.05K ﹤0.01% 2408
2023
Q3
$214K Sell
187,750
-1,068
-0.6% -$1.22K ﹤0.01% 2475
2023
Q2
$173K Hold
188,818
﹤0.01% 2501
2023
Q1
$106K Sell
188,818
-3,165
-2% -$1.77K ﹤0.01% 2578
2022
Q4
$111K Sell
191,983
-3,932
-2% -$2.27K ﹤0.01% 2653
2022
Q3
$60K Sell
195,915
-29,725
-13% -$9.1K ﹤0.01% 2728
2022
Q2
$78K Sell
225,640
-30,327
-12% -$10.5K ﹤0.01% 2695
2022
Q1
$182K Sell
255,967
-60,080
-19% -$42.7K ﹤0.01% 2481
2021
Q4
$713K Sell
316,047
-90,633
-22% -$204K ﹤0.01% 2312
2021
Q3
$1.17M Sell
406,680
-52,400
-11% -$151K ﹤0.01% 2120
2021
Q2
$1.74M Buy
459,080
+6,671
+1% +$25.3K ﹤0.01% 2001
2021
Q1
$1.53M Buy
452,409
+8,620
+2% +$29.2K ﹤0.01% 2028
2020
Q4
$1.24M Buy
443,789
+249,812
+129% +$699K ﹤0.01% 2018
2020
Q3
$484K Sell
193,977
-73,911
-28% -$184K ﹤0.01% 2407
2020
Q2
$3.63M Buy
267,888
+151,768
+131% +$2.06M 0.01% 1291
2020
Q1
$880K Buy
116,120
+2,759
+2% +$20.9K ﹤0.01% 1905
2019
Q4
$716K Buy
+113,361
New +$716K ﹤0.01% 2272
2019
Q2
Sell
-53,960
Closed -$442K 2855
2019
Q1
$442K Buy
53,960
+1,628
+3% +$13.3K ﹤0.01% 2386
2018
Q4
$289K Buy
52,332
+21,900
+72% +$121K ﹤0.01% 2501
2018
Q3
$268K Buy
30,432
+6,860
+29% +$60.4K ﹤0.01% 2586
2018
Q2
$236K Sell
23,572
-22,637
-49% -$227K ﹤0.01% 2601
2018
Q1
$440K Buy
46,209
+6,663
+17% +$63.4K ﹤0.01% 2508
2017
Q4
$612K Sell
39,546
-38,094
-49% -$590K ﹤0.01% 2363
2017
Q3
$1.53M Buy
77,640
+7,571
+11% +$149K ﹤0.01% 1928
2017
Q2
$1.01M Sell
70,069
-19,398
-22% -$279K ﹤0.01% 2114
2017
Q1
$823K Buy
89,467
+78,742
+734% +$724K ﹤0.01% 2205
2016
Q4
$111K Buy
+10,725
New +$111K ﹤0.01% 2847